Integral Derivatives’s Aetna Inc AET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$913K Buy
5,400
+1,900
+54% +$341K 0.02% 260
2017
Q4
$631K Sell
3,500
-1,100
-24% -$189K 0.01% 649
2017
Q3
$731K Buy
4,600
+2,100
+84% +$328K 0.01% 607
2017
Q2
$380K Hold
2,500
0.01% 787
2017
Q1
$319K Sell
2,500
-11,000
-81% -$1.38M 0.01% 888
2016
Q4
$1.67M Buy
13,500
+100
+0.7% +$12K 0.03% 362
2016
Q3
$1.55M Sell
13,400
-2,300
-15% -$270K 0.03% 326
2016
Q2
$1.92M Buy
+15,700
New +$1.8M 0.05% 250
2015
Q3
Sell
-9,200
Closed -$1.17M 1324
2015
Q2
$1.17M Buy
+9,200
New +$1.05M 0.03% 470
2014
Q1
Sell
-16,100
Closed -$1.1M 1692
2013
Q4
$1.1M Buy
+16,100
New +$1.05M 0.02% 742

Other funds holding AET

Integral Derivatives's AET Position: Q1 2018 in Review

Integral Derivatives sold out of Aetna Inc (AET) in Q1 2018, closing a stake of 25,962 shares — an estimated $4.67M sold.

Integral Derivatives first reported a position in AET in Q4 2014 and held it in 9 quarters. The position peaked at $4.68M in Q4 2017. 1,004 funds tracked by Wall St. Rank hold AET as of Q1 2018.

  • Integral Derivatives reported no remaining Aetna Inc position as of Q1 2018 after selling out during the quarter.
  • Integral Derivatives sold 25,962 Aetna Inc shares in Q1 2018, an estimated $4.67M.
  • Integral Derivatives first reported a position in Aetna Inc in Q4 2014 and held it in 9 quarters.
  • Integral Derivatives's Aetna Inc position peaked at $4.68M in Q4 2017.
  • 1,004 funds tracked by Wall St. Rank held Aetna Inc as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.